Healthcare
from24/7 Wall St.
2 weeks agoEli Lilly Ranks Among Top Large-Cap Performers as GLP-1 Drug Sales Exceed Billions
Eli Lilly's GLP-1 weight-loss and diabetes drugs drove blockbuster sales and market leadership, making it a top-performing, high-valuation healthcare growth stock.